These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 29278705

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cavin-2 in oral cancer: A potential predictor for tumor progression.
    Unozawa M, Kasamatsu A, Higo M, Fukumoto C, Koyama T, Sakazume T, Nakashima D, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
    Baba T, Sakamoto Y, Kasamatsu A, Minakawa Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
    [Abstract] [Full Text] [Related]

  • 6. miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.
    Wang XC, Ma Y, Meng PS, Han JL, Yu HY, Bi LJ.
    Oral Oncol; 2015 Jul; 51(7):674-82. PubMed ID: 25962939
    [Abstract] [Full Text] [Related]

  • 7. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
    Ishida S, Kasamatsu A, Endo-Sakamoto Y, Nakashima D, Koide N, Takahara T, Shimizu T, Iyoda M, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):339-345. PubMed ID: 28017725
    [Abstract] [Full Text] [Related]

  • 8. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
    Minakawa Y, Kasamatsu A, Koike H, Higo M, Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2013 Jan 29; 8(12):e85951. PubMed ID: 24386490
    [Abstract] [Full Text] [Related]

  • 9. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
    Shimizu T, Kasamatsu A, Yamamoto A, Koike K, Ishige S, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2012 Jan 29; 7(9):e45510. PubMed ID: 23029062
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 29; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H, Osawa K, Shin M, Ishikawa A, Matsuo K, Khan M, Aoki K, Ohya K, Okamoto M, Tominaga K, Takahashi T, Nakanishi O, Jimi E.
    Int J Cancer; 2012 Sep 01; 131(5):E625-35. PubMed ID: 22262470
    [Abstract] [Full Text] [Related]

  • 13. Evidence for Critical Role of Lymphocyte Cytosolic Protein 1 in Oral Cancer.
    Koide N, Kasamatsu A, Endo-Sakamoto Y, Ishida S, Shimizu T, Kimura Y, Miyamoto I, Yoshimura S, Shiiba M, Tanzawa H, Uzawa K.
    Sci Rep; 2017 Feb 23; 7():43379. PubMed ID: 28230172
    [Abstract] [Full Text] [Related]

  • 14. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC.
    Mol Cancer; 2014 Nov 26; 13():254. PubMed ID: 25424420
    [Abstract] [Full Text] [Related]

  • 15. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    Cancer Med; 2015 May 26; 4(5):759-69. PubMed ID: 25644496
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K, Bukawa H, Yokoe H, Tanzawa H.
    Int J Oncol; 2006 Apr 26; 28(4):873-81. PubMed ID: 16525636
    [Abstract] [Full Text] [Related]

  • 17. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE, Vincent-Chong VK, Ramanathan A, Kallarakkal TG, Karen-Ng LP, Ghani WM, Rahman ZA, Ismail SM, Abraham MT, Tay KK, Mustafa WM, Cheong SC, Zain RB.
    Int J Med Sci; 2015 Apr 26; 12(12):937-45. PubMed ID: 26664254
    [Abstract] [Full Text] [Related]

  • 18. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ, Huang YS, Lin CK, Huang SH, Shih HM, Sytwu HK, Chen YW.
    Clin Oral Investig; 2016 Apr 26; 20(3):533-40. PubMed ID: 26205068
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.